StoryOther
Linnaeus Therapeutics founded as University of Pennsylvania spinout
Linnaeus Therapeutics was founded by University of Pennsylvania scientists Todd Ridky and Christopher Natale to develop small-molecule drugs targeting aging.
More on Linnaeus Therapeutics
- ARPA-H awards Linnaeus $22M to test LNS8801 for healthspan preservation in the PROSPR trialFeb 2026
- LNS8801 demonstrates exceptional safety in phase 1/2 cancer trials with 100+ patients treated2025
- Linnaeus closes $12M Series B led by Kairos Ventures2019
- Linnaeus closes $4.4M Series A led by Kairos Ventures2018